These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 33880961)

  • 21. The seroprevalence of SARS-CoV-2 in a rural southwest community.
    Santarelli A; Lalitsasivimol D; Bartholomew N; Reid S; Reid J; Lyon C; Wells J; Ashurst J
    J Osteopath Med; 2021 Feb; 121(2):199-210. PubMed ID: 33567087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sero-Prevalence of SARS-CoV-2 Antibodies in High-Risk Populations in Vietnam.
    Hasan T; Pham TN; Nguyen TA; Le HTT; Van Le D; Dang TT; Van TD; Pham YN; Nguyen HV; Tran GL; Nguyen VTC; Nguyen TT; Truong VQ; Dao TH; Le CT; Truong NT; Vo HT; Le PT; Nguyen TT; Van Luu V; Nguyen VD; Toelle BG; Marks GB; Fox GJ
    Int J Environ Res Public Health; 2021 Jun; 18(12):. PubMed ID: 34208212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Seroprevalence of SARS-CoV-2 in healthcare workers from outpatient facilities and retirement or nursing homes in a Swiss canton.
    Zürcher K; Mugglin C; Suter-Riniker F; Keller PM; Egger M; Müller S; Fluri M; Hoffmann M; Fenner L
    Swiss Med Wkly; 2021 Aug; 151():w30021. PubMed ID: 34495604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Community COVID-19 Incidence and Health Care Personnel COVID-19 Seroprevalence.
    Gohil SK; Huang SS
    JAMA Netw Open; 2021 Mar; 4(3):e211575. PubMed ID: 33688960
    [No Abstract]   [Full Text] [Related]  

  • 25. Seroprevalence of SARS-CoV-2 antibodies, associated epidemiological factors and antibody kinetics among healthcare workers in Connecticut.
    Papasavas P; Olugbile S; Wu U; Robinson K; Roberts AL; O'Sullivan DM; McLaughlin T; Mather JF; Steinberg AC; Orlando R; Kumar A
    J Hosp Infect; 2021 Aug; 114():117-125. PubMed ID: 33930487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Seroprevalence study of SARS-CoV-2 antibodies in healthcare workers following the first wave of the COVID-19 pandemic in a tertiary-level hospital in the south of Ireland.
    Faller E; Wyse A; Barry R; Conlon K; Everard C; Finnegan P; Foran C; Herlihy E; Kerr G; Lapthorne S; McGreal-Bellone A; Morrissey E; O'Sullivan D; O'Sullivan G; Eustace JA; Spillane D; Dempsey C; Benson J; Prentice M; Gallagher J; MacSharry J; Fanning LJ; O'Riordan S; Horgan M; Sadlier C
    BMJ Open; 2021 Jun; 11(6):e051415. PubMed ID: 34103324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SARS-CoV-2 Infection and Antibody Seroprevalence among UK Healthcare Professionals Working with Cancer Patients during the First Wave of the COVID-19 Pandemic.
    Favara DM; McAdam K; Cooke A; Bordessa-Kelly A; Budriunaite I; Bossingham S; Houghton S; Doffinger R; Ainsworth N; Corrie PG
    Clin Oncol (R Coll Radiol); 2021 Oct; 33(10):667-675. PubMed ID: 33941453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antibody Screening and Risk Assessment of Healthcare Professionals in the COVID-19 Pandemic].
    Gümüş HH; Demiroğlu YZ; Alışkan HE; Ödemiş İ; Ceylan Ö; Poçan AG; Karagün Ö
    Mikrobiyol Bul; 2021 Jul; 55(3):357-373. PubMed ID: 34416802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Seroprevalence of SARS-CoV-2 IgG antibodies and risk factors in health care workers at an academic medical center in Boston, Massachusetts.
    Kataria Y; Cole M; Duffy E; de la Cena K; Schechter-Perkins EM; Bouton TC; Werler MM; Pierre C; Ragan EJ; Weber SE; Jacobson KR; Andry C
    Sci Rep; 2021 May; 11(1):9694. PubMed ID: 33958668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SARS-CoV-2 Seroprevalence Among Healthcare Workers by Workplace Exposure Risk in Kashmir, India.
    Khan MS; Haq I; Qurieshi MA; Majid S; Bhat AA; Qazi TB; Chowdri IN; Sabah I; Kawoosa MF; Lone AA; Nabi S; Sumji IA; Obaid M; Kousar R
    J Hosp Med; 2021 May; 16(5):274-281. PubMed ID: 33929947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of SARS-CoV-2 Antibodies in a Multistate Academic Medical Center.
    Carter RE; Theel ES; Breeher LE; Swift MD; Van Brunt NA; Smith WR; Blanchfield LL; Daugherty EA; Chapital AB; Matson KM; Bews KA; Johnson PW; Domnick RA; Joyce DE; Geyer HL; Granger D; Hilgart HR; Turgeon CT; Sanders KA; Matern D; Nassar A; Sampathkumar P; Hainy CM; Orford RR; Vachon CM; Didehban R; Morice WG; Ting HH; Williams AW; Gray RJ; Thielen KR; Farrugia G;
    Mayo Clin Proc; 2021 May; 96(5):1165-1174. PubMed ID: 33958053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Seroprevalence of SARS-CoV-2 IgG specific antibodies among healthcare workers in the Northern Metropolitan Area of Barcelona, Spain, after the first pandemic wave.
    Barallat J; Fernández-Rivas G; Quirant-Sánchez B; González V; Doladé M; Martinez-Caceres E; Piña M; Matllo J; Estrada O; Blanco I
    PLoS One; 2020; 15(12):e0244348. PubMed ID: 33370363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Seroprevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antibodies among healthcare workers with differing levels of coronavirus disease 2019 (COVID-19) patient exposure.
    Hunter BR; Dbeibo L; Weaver CS; Beeler C; Saysana M; Zimmerman MK; Weaver L
    Infect Control Hosp Epidemiol; 2020 Dec; 41(12):1441-1442. PubMed ID: 32741406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. First documented reinfection of SARS-COV-2 in second wave from Pakistan.
    Ul-Haq Z; Khan A; Fazid S; Noor F; Yousafzai YM; Sherin A
    J Ayub Med Coll Abbottabad; 2020; 32(Suppl 1)(4):S704-S705. PubMed ID: 33754536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SARS-CoV-2 IgG response in symptomatic and asymptomatic COVID-19-infected healthcare workers.
    Cordova E; Bacelar B; Nieto F; Garibaldi F; Aguirre V; Machuca M; Badia M; Rodriguez C
    Occup Med (Lond); 2021 Aug; 71(4-5):215-218. PubMed ID: 34008016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SARS-CoV-2 Serological testing in frontline health workers in Zimbabwe.
    Rusakaniko S; Sibanda EN; Mduluza T; Tagwireyi P; Dhlamini Z; Ndhlovu CE; Chandiwana P; Chiwambutsa S; Lim RM; Scott F; Sibanda LM; Mutapi F
    PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009254. PubMed ID: 33788840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SARS-CoV-2 seroprevalence in the Vatican City State.
    Ralli M; Arcangeli A; Soave PM; Voglino MC; De-Giorgio F
    Eur J Intern Med; 2021 Apr; 86():98-99. PubMed ID: 33581980
    [No Abstract]   [Full Text] [Related]  

  • 38. Response to 'Prevalence of SARS-CoV-2 antibodies in pediatric healthcare workers (pHCWs)'.
    Greenky D; Linam M; Yaffee A; Costello BE; Murray B
    Int J Infect Dis; 2021 May; 106():279-280. PubMed ID: 33823276
    [No Abstract]   [Full Text] [Related]  

  • 39. National cross-sectional survey of 1.14 million NHS staff SARS-CoV-2 serology tests: a comparison of NHS staff with regional community seroconversion rates.
    Coltart CEM; Wells D; Sutherland E; Fowler A
    BMJ Open; 2021 Jul; 11(7):e049703. PubMed ID: 34257096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High seroprevalence for SARS-CoV-2 among household members of essential workers detected using a dried blood spot assay.
    McDade TW; McNally EM; Zelikovich AS; D'Aquila R; Mustanski B; Miller A; Vaught LA; Reiser NL; Bogdanovic E; Fallon KS; Demonbreun AR
    PLoS One; 2020; 15(8):e0237833. PubMed ID: 32797108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.